+ All Categories
Home > Documents > New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Date post: 23-Feb-2016
Category:
Upload: tadeo
View: 39 times
Download: 0 times
Share this document with a friend
Description:
New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012. Aim – Discuss ways to make Cochrane findings more accessible. Help users find the Cochrane review they need Build new derivative products using components of reviews - PowerPoint PPT Presentation
Popular Tags:
33
New Users & Derivative Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Transcript
Page 1: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

New Users & Derivative ProductsTheme 3 for the Cochrane Strategic Discussion

Paris, April 2012

Page 2: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Aim – Discuss ways to make Cochrane findings more accessible

• Help users find the Cochrane review they need• Build new derivative products using

components of reviews• Better integration between CDSR & CRS

Page 3: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Should I take vitamins or supplements?

Can the Cochrane Library help me decide?

Page 4: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 5: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 6: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Issues for the small groups

• How would you like to see Cochrane content displayed?

• What are the key components of Cochrane Reviews?– That should be displayed more frequently– Are likely to have the answers users are seeking– “Key” for other reasons

• What are the barriers or problems with these innovative displays?

Page 7: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

3 EXAMPLES TO GET YOU THINKING

Page 8: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

One Possible Approach

Page 9: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 10: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 11: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 12: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

THE PICOTRON

Example #2

Page 13: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

• Cochrane Clinical Answers – succinct answers to specific clinical questions based on one or more Cochrane reviews

• The Problem – authors needed a lot of time to read the reviews & extract the succinct answers

• The Solution – The PICOtron – new software that can read & summarize Cochrane reviews

The Issues

Page 14: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

PICOtron Components

• Title• Abstract Conclusions• Methods – Types of

Participants, Interventions, Outcome Measures

• Results – Risk of Bias• Results – Data & Analyses• Figures – Forest Plots• Conclusions – Implications

for Practice

navigatingeffectivetreatments.org.au/

Page 15: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

LINKING TRIALS IN CENTRAL WITH COCHRANE REVIEWS

Example #3

http://rnd.wiley.com:8050/

Page 16: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

http://rnd.wiley.com:8050/

Page 17: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 18: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 19: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 20: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 21: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

The Cochrane Collaboration could do more of this

• Structure of Cochrane content• Recent advances in technology

– No need for a long explanation, but here’s an idea of how it could work

– See recent talks by Chris Mavergames for more detail (links in the discussion forum)

Page 22: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

IMS data feed to Wiley

CDSR

CENTRAL

CENTRAL CRSArchie RevMan

Dow

nstr

eam

Ups

trea

m

Wiley Processing

Wiley Rendering

Our Current Process

Page 23: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

IMS data feed to Wiley

CDSR

CENTRAL

CENTRAL CRSArchie RevMan

Dow

nstr

eam

Ups

trea

m

Wiley Processing

Wiley Rendering

PICOtron

Author Summaries

Page 24: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

IMS data feed to Wiley

CDSR

CENTRAL

CENTRAL CRSArchie RevMan

Dow

nstr

eam

Ups

trea

m

Wiley Processing

Wiley Rendering

Demo of Trial/Review

Linkage

Wiley gears

Page 25: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Flexible Delivery of Cochrane Content

Cochrane Library

(publisher)

Entity Web Sites

Cochrane.org Derivative Products

CENTRAL Data store CRS Archie RevMan

Linked data sets from

others

Dow

nstr

eam

Ups

trea

m

Page 26: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

First Small Group

• Start with an individual task– How would you like to see Cochrane content

displayed?– Draw a sketch to describe it

Page 27: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 28: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Sketching

• A conversation starter• Not a drawing• Neater isn’t better• Mistakes are encouraged • Might be all text

Page 29: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Convene Small Group

• Present & Explain your sketch– Start the conversation

• What are the key components of Cochrane Reviews?– That should be displayed more frequently– Are likely to have the answers users are seeking– “Key” for other reasons

Page 30: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

Second Small Group

• Identifying Barriers or Issues• What will we need to address to make this

happen?

Page 31: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 32: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012
Page 33: New Users & Derivative  Products Theme 3 for the Cochrane Strategic Discussion Paris, April 2012

navigatingeffectivetreatments.org.au/


Recommended